Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.
Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.
Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.
Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.
Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.
Recovery time varies but typically involves several weeks. Full recovery can take months, depending on the complexity of the surgery.
Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease.
Anyone at risk of hepatitis B exposure or needing routine screening should undergo this test. This includes individuals with potential exposure through sexual contact, blood transfusions, or needle-sharing.
Yes, the HBSAg Spot Test is highly accurate in detecting hepatitis B surface antigen. However, a positive result requires confirmation through additional tests.
No, additional tests are needed to differentiate between acute and chronic hepatitis B infection.
A positive result indicates possible hepatitis B infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.